Civil Litigation,
Intellectual Property
Dec. 18, 2019
Irell scores $752M win in patent case over cancer-fighting treatment
Attorneys for Gilead Sciences Inc. asked a Los Angeles federal judge Tuesday to postpone entering judgment of a $752 million verdict as the defendant prepares post-trial motions challenging a jury’s conclusion the Bristol-Myers Squibb Co. patent is valid.
Attorneys for Gilead Sciences Inc. asked a Los Angeles federal judge Tuesday to postpone entering judgment of a $752 million verdict as the defendant prepares post-trial motions challenging a jury's conclusion the Bristol-Myers Squibb Co. cancer treatment patent is valid.
The bid to delay judgment followed the jury's sweeping victory for Irell & Manella LLP partner Morgan Chu, along with attorneys from his firm and from Jones Da...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
